Many serious conditions start with symptoms that appear harmless, making it crucial to pay attention to your body's signals.

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...